Logo-jre

Editorial Policies

Outline

The Journal of Renal Endocrinology approves the guidelines of the Committee on Publication Ethics (COPE), the World Association of Medical Editors policies (WAME), and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

Authorship

As stated in the International Committee of Medical Journal Editors (ICMJE) Recommendations, credit for authorship requires:

  1. Substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data,
  2. The drafting of the article or critical revision for important intellectual content;
  3. Final approval of the version to be published;
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.

Authorship credit should be based only on substantial contributions to each of the four components mentioned above. Those who do not meet all four criteria should be acknowledged.

The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. In addition, any changes must be explained to the Editor/Editor-in-Chief.  In line with COPE guidelines, our journal requires written confirmation from all authors that they agree with any proposed changes in authorship of submission(s) or published item(s). This approval must be via direct email from each author. It is the corresponding author’s responsibility to ensure that all authors agree with the suggested changes. It is not the journal editor’s responsibility to resolve authorship disputes. A change in authorship of a published article can only be amended via publication of an Erratum or Correction.

Authors should follow "the international standards for authors" recommended by COPE.

Authors' responsibilities

-Authors must certify that their manuscripts are their original work.

-Authors must certify that the manuscript has not previously been published elsewhere.

 -Authors must certify that the manuscript is not currently being considered for publication elsewhere.

 -Authors must participate in the peer-review process.

 -Authors are obliged to provide retractions or corrections of mistakes.

 -All Authors mentioned in the paper must have significantly contributed to the research.

 -Authors must state that all data in the paper are real and authentic.

 -Authors must notify the editors of any conflicts of interest.

 -Authors must identify all sources used in the creation of their manuscript.

 -Authors must report any errors they discover in their published paper to the editors.

Reviewers' responsibilities

  • Reviewers should keep all information regarding papers confidential
  • Reviews should be conducted objectively, with no personal criticism of the author
  • Reviewers should express their views obviously with supporting arguments
  • Reviewers should identify relevant published work that has not been cited by the authors.
  • Reviewers should also call to the editor-in-chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
  • Reviewers should not review manuscripts in which they have conflicts of interest resulting from relationships or connections with any of the authors or institutions linked to the papers.

Editors' responsibilities

  • Editors have complete responsibility to reject/accept an article.
  • Editors are responsible for the contents and overall quality of the publication.
  • Editors should guarantee the quality of the papers and the integrity of the academic record.
  • Editors should base their decisions solely one the papers' importance, novelty and relevance to publication's scope.
  • Editors should preserve the anonymity of reviewers.
  • Editors should ensure that all research material they publish conforms to ethical guidelines accepted by the journal.
  • Editors should only accept a paper when reasonably certain.
  • Editors should not reject papers based on suspicions, they should have proof of misconduct.
  • Editors should not allow any conflicts of interest between Editorial office, authors, reviewers, and editorial board members.

Clinical Trial Registry

Based on the ICMJE recommendations a clinical trial is defined as “any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect, relationship between a health-related intervention and a health outcome.” In agreement with the ICMJE’s recommendations, The Journal of Renal Endocrinology would consider publishing clinical trials that have been registered with a clinical trial registry that allows free online access to public. As per our policy, registration of all trials in a public registry approved by the ICJME -- a primary register of the WHO International Clinical Trials Registry Platform available from the following link:

www.who.int/ictrp/network/primary/en/index.html.

Research Reporting Guidelines

Authors are encouraged to use the EQUATOR Network reporting guidelines for the study type:

  • Randomized controlled trials (RCTs): CONSORT guidelines
  • Systematic reviews and meta-analyses: PRISMA guidelines and MOOSE guidelines
  • Observational studies in epidemiology: STROBE guidelines and MOOSE guidelines
  • Diagnostic accuracy studies: STARD guidelines
  • Quality improvement studies: SQUIRE guidelines
  • Case reports guidelines: CARE guidelines

Ethical Policies

Journal of Renal Endocrinology expects the highest ethical standards from their authors, reviewers and editors when conducting research, submitting papers and throughout the peer-review process.

Journal of Renal Endocrinology adheres to the policies of the Committee on Publication Ethics (COPE)World Association of Medical Editors (WAME), and International Committee of Medical Journal Editors (ICMJE) recommendations Thus, The Journal of Renal Endocrinology expects all authors, reviewers and editors to consider COPEICMJE and Equator Network’s reporting guidelines in scientific writing.

Human and animal ethics

Authors reporting experimental studies on human subjects must include an ethical approval statement in Title page indicating (a) informed consent was taken from all patients enrolled in the study and (b) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. For protecting the safety individuals who participate in study, academic and funding organizations

require any study including human participants be approved by an institutional review board (IRB) or ethics review committee. In studies involving animal experimentations, all criteria highlighted in the "Guide for the Care and Use of Laboratory Animals" should be addressed.

Process for Identification of and Dealing with Allegations of Research Misconduct

The publisher [Nickan Research Institute (http://nickanrescorp.com/)] and the Editor-in-Chief (Prof. Mohammad Reza Tamadon) of the Journal of Renal Endocrinology (eISSN: 2423-6438) will take reasonable steps which comprise technological and personal knowledge available to identify and block the publication of manuscripts where research misconduct has arisen, containing citation manipulation, plagiarism, and data falsification/fabrication among others. The Journal of Renal Endocrinology follows COPE's guidelines (http://publicationethics.org/resources/guidelines) in dealing with allegations.

Patient consent and confidentiality

Any article that contains personal medical information about an identifiable living individual requires the patient’s explicit consent before we can publish it. We would like the patient to sign our consent form, which requires the patient to have read the article.

If consent cannot be obtained because the patient cannot be traced then publication will be possible only if the information can be sufficiently anonymized. In other words, neither the patient nor anyone else could recognize the patient with certainty.

If the patient is dead the authors should seek permission from a relative (as a matter of courtesy and medical ethics). If the relatives are not contactable we will balance the worthwhileness of the case, the likelihood of identification, and the likelihood of offence if identified in making a decision on whether we should publish without a relative’s consent.

Our policy on obtaining consent for publication of pictures of patients is a subset of our general policy on patient confidentiality. Images – such as X- rays, laparoscopic images, ultrasound images, pathology slides, or images of undistinctive parts of the body – may be used without consent so long as they are anonymized by the removal of any identifying marks and are not accompanied by text that could reveal the patient’s identity through clinical or personal detail.

Competing Interest Statement

In medical publication, a conflict of interest (COI) happens when an author has financial or other relationships influencing the author’s decisions, work, or manuscript. COI may occur in various forms such as financial ties, academic commitments, personal relationships, political or religious beliefs, and institutional affiliations. In managing COI, The Journal of Renal Endocrinology abides by the policy statement of the WAME. All authors should declare their COI, if any, during the manuscript submission. Additionally, reviewers and editors are requested to announce their COI when they agree to take a manuscript for reviewing and handling, respectively. Reviewers and Editors with COI will be excepted from the manuscript process. All authors must declare all competing interests in their title page. Further information can be found at the following links:

http://www.icmje.org/recommendations/  

https://publicationethics.org/competinginterests  and the World Association of Medical

http://wame.org/wame-editorial-on-conflict-of-interest

Peer Review Process

All submissions to the journal go through a Double-Blind Peer-Review Process. A peer review system including two or three reviewers is applied to guarantee quality of manuscripts accepted for publication. Our Editors have the right to decline review process of the manuscript when manuscript: (a) focused on a subject outside the aim and scope of the Journal, (b) has technical errors, (c) has no novelty and is written in poor English.

This review consists of the following steps: 

1.      At the first stage, a staff from Editorial Office will check format and style of manuscript to assure that it is suitable to go through the normal peer review process. If authors have not considered the guides, the manuscript will be sent back to authors for compatibility.

2.     Submissions are then assigned to an Editor for evaluation.

3.     The Editor decides whether reviews from additional experts are needed to evaluate the manuscript. All submitted manuscripts to the Journal of Renal Endocrinology are subject to a strict peer-review process by at least two international reviewers and one local reviewer that are experts in the area Nephrology/Endocrinology.

4.     After evaluation, the Editor chooses between the following decisions:

  • Accept
  • Minor Revision
  • Major Revision
  • Reject

    If the decision is Minor Revision or Major Revision, authors have 35 days to resubmit the revised manuscript. Authors may contact email address if they require an extension.  Upon resubmission, the Editor may choose to send the manuscript back to external reviewers, or may make a decision based on personal expertise. Finally, Managing Editor receives the reviewers’ comments and sends them along with decision letter to corresponding author. Final decision on each manuscript will be made by the Editor-in-Chief.

    Note: If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted. Rejected manuscripts will not be re-reviewed. No research can be included in more than one publication

    Duties of Editors

    Publication decisions
    The editors of the Journal are responsible for deciding which of the articles submitted to the journal should be published. They are guided by the policies of the journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.  They actively work to improve the quality of the journal.

    Fair play
    The editor evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

    Confidentiality
    The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

    Duties of Reviewers

    Contribution to Editorial Decisions
    Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.

    Promptness
    Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the.

    Confidentiality
    Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

    Editorial Freedom at the Journal of Renal Endocrinology

    TheJournal of Renal Endocrinology adheres to the World Association of Medical Editors (WAME) Policy on “The Relationship between Journal Editors-in-Chief and Owners. More specifically, the Editor-in-Chief has editorial independence and as such has full authority over the journal’s editorial content including how and when information is published. Editorial decisions are based solely on the validity of the work and its importance to readers, not on the policies or commercial interests of the owner.  Neither the Publisher nor other organizations interfere in the evaluation, selection or editing of individual articles, either directly or by creating an environment in which editorial decisions are influenced.

    Withdrawal, Corrections and Retractions policies

    As a follower of the COPE, Journal of Renal Endocrinology adheres to the “Code of Conduct” and the “Best Practice Guidelines” and "Principles of Transparency and Best Practice in Scholarly Publishing".

    Withdrawal

    Withdrawal is an action that takes the manuscript out of the review process and places it back into the author’s dashboard. In general, we do not suggest article withdrawal, since it wastes valuable manuscript processing time, money and works invested by the publisher.

    Withdrawal Policies

    • Pre-Review: The author(s) can withdraw their papers at this step without posting compelling reasons.
    • Peer-Review, Final Decision, and Pre-Publication: The authors should have compelling reasons in order to withdraw their papers.
    • Post-Publication: Withdrawing at this step is not possible at all.

    When a withdrawal occurs, our publisher will remove the article content (HTML and PDF) and replace with a HTML page describing that the article has been withdrawn according to the Publisher’s policies.

    See COPE Cases for details.

    Correction

    Journal of Renal Endocrinology  will consider the publication of a correction when a mistake may jeopardize the conclusions of an article or contains incorrect information regarding metadata of an article such as author names, affiliations, title, etc) but does not undermine the validity of the findings. A note linking to the correction will be placed in the original article page.

    Redundant publication

    Duplicate or redundant submission is the same manuscript (or the same data) that is submitted to different journals at the same time. In such case, we will follow the COPE guidelines.

    Note: ICMJE recommends that translations are acceptable but MUST reference the original. Based on our policy, translations of original article can be considered as an online supplementary file. Editors may consider publishing a correction rather than a retraction/notice of duplicate publication in such cases.

    Retraction

    In keeping with COPE's Retraction Guidelines, a retraction will be considered by our editors if: 

  • It has clear evidence indicating the results are unreliable, either because of major errors (eg, miscalculation or experimental error, data fabrication, image manipulation, …)
  • It has plagiarism.
  • The findings have previously been published elsewhere without proper citation to previous sources, permission to reproduce, or justification (ie, cases of redundant publication)
  • There is a copyright infringement or other legal issues
  • It reports unethical research
  • It has been published solely on the basis of a compromised or manipulated peer review process
  • The author(s) failed to declare a major conflict of interest

Authors or editors of the journal may retract a paper. However, the final decision is made by the editors for retracting the material. If none of the authors will approve to publish a retraction, the editor/s may request such a retraction from the investigating institution, or the editor may ask a retraction on behalf of the journal. In each condition, the editor should inform the author(s) or institution affiliated to the author(s) for publishing a retraction.

  • Note: After publishing a retraction, HTML version of the document will be removed from the site. Additionally, The PDF file of the article is retained unchanged; only a watermark showing “retracted” label is placed on each page of the PDF. Finally, a link is made to the original article.

Citation Manipulation

Submitted papers that are found to include citations whose primary purpose is to increase the number of citations to a given author’s article, or to articles published in a particular journal, will incur citation manipulation sanctions.

Plagiarism

Journal of Renal Endocrinology is powered by the iThenticate software, a plagiarism detector service that considers the originality of content submitted before publication. When plagiarism is identified, we act based on flowcharts and workflows determined in COPE.

Plagiarism contains, but is not limited to:

    • Directly copying text from other sources
    • Using an idea from another source with a little altered language
    • Copying ideas, images, or materials/data from other sources
    • Reusing text from your previous publications

Plagiarism Policies

    • If plagiarism is identified during the peer review stage, the manuscript may be rejected.
    • If plagiarism is identified after publication of the article, we reserve the right to request a correction or retract the paper based on COPE guidelines.

      CrossMark Policy

      CrossMark is a multi-publisher initiative to provide a standard method for readers to find the current version of a piece of content. By applying the CrossMark logo, our journal is committing to maintaining the content it and to notifying readers to changes if and when they occur.

      All articles have the CrossMark logo in PDF or HTM files. Clicking on the CrossMark logo at the top of each article in PDF and HTML file will indicate the current status of a document and may also give additional information about the document.

      For more details on CrossMark, please refer the CrossMark website at the following link:

      https://www.crossref.org/services/crossmark/.

      Editorial Board Policy

      The selection of Editorial/Advisory Board is a vital stage. We choose our editors in keeping with quantity and the quality published articles, citation of her/his works together with the "H-index". Journal of Renal Endocrinologyfollows to “the COPE Best Practice Guidelines for Journal Editors” regarding the selection of them.

      Editor-in-Chief

      He is the lead editor playing the vital role to guarantee integrity and quality of content of the submitted manuscript. EIC must have at least a PhD/MD degree to be able to lead the publication process. Based on Scopus database, the minimum h-index for the Editor-in-Chief is 14. He has some responsibilities as follows:

    • Making an overall plan for improving quality of the content regarding submitted manuscripts
    • Reviewing and making the final decision for the submitted manuscripts
    • Identifying qualified editorial board members who can contribute to the progress and management of the journal
    • Handling meetings in order to interact with all the members of the Editorial Board regarding code conducts, standards, and new policies of the Journal.


    Associate Editors

    Associate editors are responsible for peer-review process and ensuring publication of high-quality papers. They would help the lead editor in terms of different aspects related to the works of publication, and peer review process.


    Editorial Board Members

    The Editorial Board Members must be familiar with the peer-review process, publication ethics and code of conduct as well as standards for high-quality publications. Academic merit/competency and having high H-index are two main top factors for selecting editorial board members.


    Publication Charge

    This journal is a platinum open access. Therefore, there is no publication fee in this journal.


    Article Sharing Guidelines

    The following points highlight our policies regarding manuscripts submitted to Journal of Renal Endocrinology:

     1- Submitted version of article: The authors submitting articles to Journal of Renal Endocrinology are banned from publication of the submitted data (except for registries required for clinical trials) in an open repository before its acceptance.

    2- Accepted version of article: The authors can deposit their manuscript in open repositories after acceptance in the journal process without any embargo policy.

    3- Final version of article (PDF format): We encourage authors to share the final PDF version of their article in open repositories.


    Advertising Policy

    At present, Journal of Renal Endocrinology does not publish any advertisement. This journal also has not any direct marketing activities, including the solicitation of manuscripts.